Thoracic Outlet Syndrome Thoracic Outlet Syndrome/Brachial Plexopathy. In Memory Of DeAnne Marie.


advertisement
Reply
 
Thread Tools Display Modes
Old 06-09-2007, 06:00 PM #1
ocgirl's Avatar
ocgirl ocgirl is offline
Member
 
Join Date: Aug 2006
Location: southern Calif
Posts: 221
15 yr Member
ocgirl ocgirl is offline
Member
ocgirl's Avatar
 
Join Date: Aug 2006
Location: southern Calif
Posts: 221
15 yr Member
Default correction to Newsweek's article on pain

If you haven't read Newsweek's article I have included it in addition to the correction.
There is an interactive picture at the top of the article that tells how pain travels in the body that I found very interesting.
Be sure to keep scrolling down as the article is large and divided by advertisements
It sounds hopeful that there are new treatments on the horizon.

There is a lot of good information in this article. I wish I had access to this about 7 years ago.

;Home | About Us | Contact Us | Support Us


Media Alert
June 8, 2007


A Correction of the Newsweek Story
The Newsweek cover story, “The Changing Science of Pain” (6/4/07), refers to the challenge of treating the chronic pain that over 75 million Americans suffer each day. The article touched briefly on the delicate balance needed to provide relief from chronic pain, while also minimizing the risk of abuse by those who might alter the way it is meant to be taken.
Near the beginning of the article it states that “Patients can still become dependent on a new form of the morphine derivative called Kadian, for instance, but if they crush one of the pills for snorting, its center explodes, releasing a substance that block the euphoric high.” Kadian, which is currently on the market, does not contain a substance that blocks the euphoric high.
Currently, the long acting forms of morphine, like Kadian, Avinza and MSContin, do not have a reversal medication (opioid antagonist) included in their formulation as that sentence implies. However, there are other opioid formulations with antagonists or other tamper resistant properties under investigation or clinical trials with pharmaceutical companies like Alpharma (the maker of Kadian), Pain Therapeutics and Purdue Pharma.
Newsweek has notified APF that they will be running a clarification to this effect in next week's issue.


Last edited by ocgirl; 06-09-2007 at 06:21 PM.
ocgirl is offline   Reply With QuoteReply With Quote

advertisement
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Good pain article Wing42 Peripheral Neuropathy 25 06-06-2007 07:39 PM
newsweek's article on pain Abbie Reflex Sympathetic Dystrophy (RSD and CRPS) 2 05-29-2007 06:51 PM
Diabetic PN. Pain.com Article. Adastra Peripheral Neuropathy 6 05-28-2007 08:57 AM
Article on Pain treatment center HeyJoe Peripheral Neuropathy 6 03-25-2007 10:33 AM
2004 Article on Pain Silverlady Peripheral Neuropathy 0 10-05-2006 09:46 PM


All times are GMT -5. The time now is 07:40 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.